• TRADE NAMES: Forsteo; Forteo (Lilly)
  • INDICATIONS: Osteoporosis in postmenopausal women and men at increased risk of fractures
  • CLASS: Parathyroid hormone analog
  • HALF-LIFE: 1 hour
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Alcohol, Digoxin

POTENTIAL RISK OF OSTEOSARCOMA

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 10/21/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric